The global biopharmaceutical excipients market was valued at $1.67 billion in 2017 and is expected to grow at a CAGR of 6.08% through 2025. Key drivers of growth include the expansion of the biopharmaceutical industry and increasing production capacities. Carbohydrates currently have the largest market share due to wide use of excipients like dextrose, sucrose, and starch. Polyols are projected to be the fastest growing segment due to their ability to reduce protein degradation. North America currently leads the market due to major biopharmaceutical manufacturers located in the US.

1. FollowUs:
Biopharmaceutical Excipients Market Major Key Players, Latest Trend
Analysis And Forecast Till 2025| Grand View Research, Inc
The global biopharmaceutical excipients market size is expectedto reach USD 2.7 billionby 2025, according to a
new report by Grand ViewResearch, Inc. It is anticipated to expandat a CAGR of 6.08% over the forecast period.
Rapid expansionof the biopharmaceutical industry due to increasing manufacturing capacities is one of the key
driving force of this market. Rise in the number of protein therapeutics coupled with the presence of a substantial
number of excipientsto protect these proteins from degradation is also driving the market growth.
Investigational studiesthat are implementedforthe impact analysis of excipientvariabilityon in vitro dissolution
testing are expectedto reduce the attrition rate of final products and increase the reproducibility.These studies
helpscientists in gaining insightson the in vivo functioningand pharmacodynamic analysis of large molecules.The
market exhibitscontinuous needof innovative excipienttechnologiesto prolong the in vivo effectivenessof
biologicsand for improvementin the product delivery.Moreover, extensive R&D for the developmentof raw
materials that helpimprove yieldsin mammalian cell-culture processesis expectedto drive the market in future.
Browse Details of Report @ www.grandviewresearch.com/industry-analysis/biopharmaceutical-excipients-
market
“The global biopharmaceutical excipientsmarket sizewas valued at USD 1.67
billion in 2017.It is poised to witness a CAGR of 6.08% during the forecast
period.”

2. FollowUs:
Further key findings from the study suggest:
 Easy availabilityand wide usage of dextrose,sucrose, and starch in biopharmaceutical formulations has
resultedin the largest revenue share of carbohydrates
 Polyolsis expectedto be the fastest-growingproduct segmentin the global biopharmaceutical excipients
market
 This can be attributed to increasing concerns regarding protein degradation, which can be reduced by using
polyols
 North America ledthe global market in 2017 accounting for the largest revenue share as a result of the
presence of keybiopharmaceutical manufacturers in U.S.
 Emerging markets, such as India and China, are projected to be driven by the contract manufacturers
operating in these regions
 Some major biopharmaceutical excipientsuppliersare Merck KGaA; Roquette; Clariant; DFE Pharma; SPI
Pharma, Inc.; and JRS Pharma LP
 Most of these companies are engaged in establishingpartnerships with biopharmaceutical manufacturers to
understand their needsand developraw materials specific to the process and end-product.
Grand ViewResearch has segmentedthe global biopharmaceutical excipientsmarket on the basis of product and
region:
Biopharmaceutical Excipients Product Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
 Solubilizers& Surfactants/Emulsifiers
o Triglycerides
o Esters
o Others
 Polyols
o Mannitol
o Sorbitol
o Others
 Carbohydrates
o Dextrose
o Sucrose
o Starch
o Others
 Specialty Biopharmaceutical Excipients/Others

3. FollowUs:
Biopharmaceutical Excipients Regional Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
 North America
o U.S.
o Canada
 Europe
o Germany
o U.K.
 Asia Pacific
o Japan
o China
o India
o Malaysia
o South Korea
o Philippines
o NewZealand
o Australia
o Singapore
o Indonesia
 Latin America
o Brazil
 Middle East & Africa
o South Africa
Browse Related Category Reports @ https://www.grandviewresearch.com/industry/pharmaceuticals
Table of Content of Biopharmaceutical Excipients Market
Chapter 1 Executive Summary
1.1 Market Snapshot
Chapter 2 ResearchMethodology
2.1 InformationProcurement
2.1.1 Purchased Database
2.1.2 GVR’sInternal Database

4. FollowUs:
2.2 Data Analysis
2.3 Market Formulation&Validation
2.4 ApproachesforMarket Estimation
2.4.1 Approach1: CommodityFlow &BottomUp Approach
2.4.2 Approach2: Top Down andParentMarket Analysis
Chapter 3 Global Biopharmaceutical ExcipientsMarket Variables,Trends& Scope
3.1 Market Segmentation&Scope
3.1.1 Market driveranalysis
3.1.1.1 Chemical andphysical instabilityof biopharmaceuticalsdrivesdevelopmentof excipients
3.1.1.2 Increase infocusof pharmaplayersonbiogenericmarket
3.1.1.3 Cost-efficiencyandcompetencyof manufacturers
3.1.1.4 Patentexpiryof biological actives
3.1.1.5 Risingadoptionof multifunctionalityexcipients
3.1.1.6 Ongoingstudies andtechnological advancementstoenhance the final productbioavailabilityusing
excipients
3.1.2 Market restraintanalysis
3.1.2.1 Challengesindevelopmentof excipientsforbiologics
3.1.2.2 Issuespertainingtosupplychaininbiopharmaceutical industry
3.2 Penetration&GrowthProspectMappingfor Products,2017
3.3 Global Biopharmaceutical ExcipientsMarket-SWOTAnalysis,ByFactor(Political &Legal,EconomicAnd
Technological)
3.4 IndustryAnalysis - Porter’s
Chapter 4 Global Biopharmaceutical ExcipientsMarket Categorization:Product Estimates& Trend Analysis
4.1 Global Biopharmaceutical ExcipientsMarket:ProductMovementAnalysis
4.2 Solubilizers&Surfactants/Emulsifiers
4.2.1 Global solubilizers&surfactants/emulsifiersmarket,byrevenue 2014 - 2025 (USD Million)
4.2.2 Global solubilizers&surfactants/emulsifiersmarket,byproduct,byvolume 2014 - 2025 (Tons)
4.2.3 Triglycerides
4.2.3.1 Global triglyceridesmarket,byrevenue 2014 - 2025 (USD Million)
4.2.3.2 Global triglyceridesmarket,byproduct,byvolume 2014 - 2025 (Tons)
4.2.4 Esters
4.2.4.1 Global estersmarket,byrevenue 2014 - 2025 (USD Million)

5. FollowUs:
4.2.4.2 Global estersmarket,byvolume by2014 - 2025 (Tons)
4.2.5 Othersolubilizer
4.2.5.1 Global othersolubilizersmarket,byrevenue2014 - 2025 (USD Million)
4.2.5.2 Global othersolubilizersmarket,byproduct,byvolume 2014 - 2025 (Tons)
4.3 Polyols
4.3.1 Global polyolsmarket,byrevenue 2014 - 2025 (USD Million)
4.3.2 Global polyolsmarket,byproduct,byvolume 2014 - 2025 (Tons)
4.3.3 Mannitol
4.3.3.1 Global mannitol market,byrevenue 2014 - 2025 (USDMillion)
4.3.3.2 Global mannitol market,byproduct,byvolume 2014 - 2025 (Tons)
4.3.4 Sorbitol
4.3.4.1 Global sorbitol market,byrevenue 2014 - 2025 (USD Million)
4.3.4.2 Global sorbitol market,byproduct,byvolume 2014 - 2025 (Tons)
4.3.5 Otherpolyols
4.3.5.1 Global otherpolyols market,byrevenue2014 - 2025 (USD Million)
4.3.5.2 Global otherpolyolsmarket,byproduct,byvolume 2014 - 2025 (Tons)
4.4 Carbohydrates
4.4.1 Global carbohydratesmarket,byrevenue 2014 - 2025 (USD Million)
4.4.2 Global carbohydratesmarket,byproduct,byvolume 2014 - 2025 (Tons)
4.4.3 Dextrose
4.4.3.1 Global dextrose market,byrevenue2014 - 2025 (USD Million)
4.4.3.2 Global dextrose market,byproduct,byvolume 2014 - 2025 (Tons)
4.4.4 Sucrose
4.4.4.1 Global sucrose market,byrevenue 2014 - 2025 (USD Million)
4.4.4.2 Global sucrose market,byproduct,by volume 2014 - 2025 (Tons)
4.4.5 Starch
4.4.5.1 Global starch market,byrevenue 2014 - 2025 (USD Million)
4.4.5.2 Global starch market,byproduct,by volume 2014 - 2025 (Tons)
4.4.6 Others
4.4.6.1 Global othercarbohydratesmarket,byrevenue 2014 - 2025 (USD Million)
4.4.6.2 Global othercarbohydratesmarket,byproduct,byvolume 2014 - 2025 (Tons)
4.5 SpecialtyBiopharmaceutical Excipients/Others

6. FollowUs:
4.5.1 Global specialtybiopharmaceutical excipients/othersmarket,byrevenue 2014 - 2025 (USD Million)
4.5.2 Global specialtybiopharmaceutical excipients/othersmarket,byproduct,byvolume 2014 - 2025 (Tons)
Chapter 5 Global Biopharmaceutical ExcipientsMarket Categorization:Regional Estimates& Trend Analysis
5.1 Global Biopharmaceutical ExcipientsMarket:Regional MovementAnalysis
5.2 North America
5.2.1 NorthAmericabiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (USD Million)
5.2.2 NorthAmericabiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (volume,Tons)
5.2.3 U.S.
5.2.3.1 U.S. biopharmaceutical excipientsMarket,byproduct,2014 - 2025 (USD Million)
5.2.3.2 U.S. biopharmaceutical excipientsMarket,byproduct,2014 - 2025 (volume,Tons)
5.2.4 Canada
5.2.4.1 Canada biopharmaceutical excipientsMarket,byproduct,2014 - 2025 (USD Million)
5.2.4.2 Canada biopharmaceutical excipients Market,byproduct,2014 - 2025 (volume,Tons)
5.3 Europe
5.3.1 Europe biopharmaceutical excipientsMarket,byproduct,2014 - 2025 (USD Million)
5.3.2 Europe biopharmaceutical excipientsMarket,byproduct,2014 - 2025 (volume,Tons)
5.3.3 Germany
5.3.3.1 Germanybiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (USD Million)
5.3.3.2 Germanybiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (volume,Tons)
5.3.4 U.K.
5.3.4.1 U.K. biopharmaceuticalexcipientsMarket,byproduct,2014 - 2025 (USD Million)
5.3.4.2 U.K. biopharmaceuticalexcipientsMarket,byproduct,2014 - 2025 (volume,Tons)
5.4 AsiaPacific
5.4.1 AsiaPacificbiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (USD Million)
5.4.2 AsiaPacificbiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (volume,Tons)
5.4.3 Japan
5.4.3.1 Japan biopharmaceutical excipientsMarket,byproduct,2014 - 2025 (USD Million)
5.4.3.2 Japan biopharmaceutical excipientsMarket,byproduct,2014 - 2025 (volume,Tons)
5.4.4 China
5.4.4.1 Chinabiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (USD Million)
5.4.4.2 Chinabiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (volume,Tons)
5.4.5 India

7. FollowUs:
5.4.5.1 IndiabiopharmaceuticalexcipientsMarket,byproduct,2014 - 2025 (USD Million)
5.4.5.2 IndiabiopharmaceuticalexcipientsMarket,byproduct,2014 - 2025 (volume,Tons)
5.4.6 Malaysia
5.4.6.1 Malaysiabiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (USD Million)
5.4.6.2 Malaysiabiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (volume,Tons)
5.4.7 SouthKorea
5.4.7.1 SouthKoreabiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (USD Million)
5.4.7.2 SouthKoreabiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (volume,Tons)
5.4.8 Philippines
5.4.8.1 Philippinesbiopharmaceutical excipientsMarket,byproduct, 2014 - 2025 (USD Million)
5.4.8.2 Philippinesbiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (volume,Tons)
5.4.9 NewZealand
5.4.9.1 NewZealandbiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (USD Million)
5.4.9.2 NewZealandbiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (volume,Tons)
5.4.10 Australia
5.4.10.1 Australiabiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (USD Million)
5.4.10.2 Australiabiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (volume,Tons)
5.4.11 Singapore
5.4.11.1 Singapore biopharmaceutical excipientsMarket,byproduct,2014 - 2025 (USD Million)
5.4.11.2 Singapore biopharmaceutical excipientsMarket,byproduct,2014 - 2025 (volume,Tons)
5.4.12 Indonesia
5.4.12.1 Indonesiabiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (USD Million)
5.4.12.2 Indonesiabiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (volume,Tons)
5.5 Latin America
5.5.1 LatinAmericabiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (USD Million)
5.5.2 LatinAmericabiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (volume,Tons)
5.5.3 Brazil
5.5.3.1 Brazil biopharmaceutical excipientsMarket,byproduct,2014 - 2025 (USD Million)
5.5.3.2 Brazil biopharmaceutical excipientsMarket,byproduct,2014 - 2025 (volume,Tons)
5.6 MEA
5.6.1 MEA biopharmaceutical excipientsMarket,byproduct,2014 - 2025 (USD Million)
5.6.2 MEA biopharmaceutical excipientsMarket,byproduct,2014 - 2025 (volume,Tons)

8. FollowUs:
5.6.3 SouthAfrica
5.6.3.1 SouthAfricabiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (USD Million)
5.6.3.2 SouthAfricabiopharmaceutical excipientsMarket,byproduct,2014 - 2025 (volume,Tons)
Chapter 6 Competitive Landscape
6.1 StrategyFramework
6.2 Market ParticipationCategorization
6.3 CompanyProfiles
6.3.1 Merck KGaA
6.3.1.1 Companyoverview
6.3.1.1.1 Merck Millipore
6.3.1.2 Financial performance
6.3.1.3 Productbenchmarking
6.3.1.4 Strategicinitiatives
6.3.2 SignetChemical CorporationPvt.Ltd.
6.3.2.1 Companyoverview
6.3.2.2 Financial performance
6.3.2.3 Productbenchmarking
6.3.2.4 Strategicinitiatives
6.3.3 Sigachi IndustriesPvt.Ltd.
6.3.3.1 CompanyOverview
6.3.3.2 Financial performance
6.3.3.3 Productbenchmarking
6.3.4 ABITEC
6.3.4.1 Companyoverview
6.3.4.2 Financial performance
6.3.4.3 Productbenchmarking
6.3.4.4 Strategicinitiatives
6.3.5 SpectrumChemical ManufacturingCorp.
6.3.5.1 Companyoverview
6.3.5.2 Financial performance
6.3.5.3 Productbenchmarking
6.3.5.4 Strategicinitiatives

9. FollowUs:
6.3.6 Roquette
6.3.6.1 Companyoverview
6.3.6.2 Financial performance
6.3.6.3 Productbenchmarking
6.3.6.4 Strategicinitiatives
6.3.7 IMCD
6.3.7.1 Companyoverview
6.3.7.1.1 IndchemInternational
6.3.7.2 Financial performance
6.3.7.2.1 Financial performance
6.3.7.3 Productbenchmarking
6.3.7.4 Strategicinitiatives
6.3.8 Pharmonix
6.3.8.1 Companyoverview
6.3.8.2 Financial performance
6.3.8.3 Productbenchmarking
6.3.9 Clariant
6.3.9.1 Companyoverview
6.3.9.2 Financial performance
6.3.9.3 Productbenchmarking
6.3.9.4 Strategicinitiatives
6.3.10 DFE Pharma
6.3.10.1 Companyoverview
6.3.10.2 Financial performance
6.3.10.3 Productbenchmarking
6.3.10.4 Strategicinitiatives
6.3.11 Colorcon
6.3.11.1 Companyoverview
6.3.11.2 Financial performance
6.3.11.3 Productbenchmarking
6.3.11.4 Strategicinitiatives
6.3.12 SPIPharma

10. FollowUs:
6.3.12.1 Companyoverview
6.3.12.2 Financial performance
6.3.12.3 Productbenchmarking
6.3.12.4 Strategicinitiatives
6.3.13 JRS PHARMA
6.3.13.1 Companyoverview
6.3.13.2 Financial performance
6.3.13.3 Productbenchmarking
6.3.13.4 Strategicinitiatives
6.3.14 BASFSE
6.3.14.1 Companyoverview
6.3.14.2 Financial performance
6.3.14.3 Productbenchmarking
6.3.14.4 Strategicinitiatives
About Us:
Grand ViewResearch, Inc. is a U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To helpclients make informed business decisions, the company offers
market intelligence studiesensuring relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist,USA
Grand ViewResearch, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: http://www.grandviewresearch.com

11. FollowUs: